4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19349768 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Oct 03, 2025 |
| 17773404 | MrgprX2 Antagonists and Uses Thereof | ENGLISH, CONNOR KENNEDY | 1625 | Non-Final OA | Apr 29, 2022 |
| 17773414 | MrgprX2 Antagonists and Uses Thereof | HEITMEIER, KENDALL NICOLE | 1621 | Final Rejection | Apr 29, 2022 |
| 17772467 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Apr 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial